Page last updated: 2024-11-01

nisoldipine and Cardiac Diseases

nisoldipine has been researched along with Cardiac Diseases in 3 studies

Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yaghi, MM1
Watts, JA2
Kauder, WF1
Pahor, M1
Tatti, P1

Trials

1 trial available for nisoldipine and Cardiac Diseases

ArticleYear
The Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET) and combination therapies.
    The American journal of cardiology, 1999, Mar-01, Volume: 83, Issue:5

    Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Block

1999

Other Studies

2 other studies available for nisoldipine and Cardiac Diseases

ArticleYear
Effects of nisoldipine upon endothelial dysfunction following ischaemic and peroxidative injury in the perfused rat heart.
    Cardiovascular research, 1993, Volume: 27, Issue:6

    Topics: Acetylcholine; Animals; Coronary Vessels; Endothelium, Vascular; Heart Diseases; In Vitro Techniques

1993
Antioxidant properties of dihydropyridines in isolated rat hearts.
    Biochemical pharmacology, 1996, Mar-22, Volume: 51, Issue:6

    Topics: Animals; Antioxidants; Calcium Channel Blockers; Heart; Heart Diseases; Hydrogen Peroxide; In Vitro

1996